Mobile Digital Health Platforms Use in TAVR

By Staff Writer

February 2, 2024

Transforming Patient Outcomes in Aortic Valve Replacement

Aortic stenosis (AS) is a condition that affects around 12.4% of the global population and seen most prevalent in the elderly with an estimated 10% of individuals over the age of 80 being affected. Traditionally, surgical aortic valve replacement (SAVR) was the only treatment method as there is no medicine to treat this condition. However, transcatheter aortic valve replacement (TAVR) is becoming increasingly popular among healthcare practitioners and patients due to its less invasive nature and similar clinical outcomes. This also allows for the option of valve replacement in severe AS.

Mobile Digital Health Platforms: The Future of Patient Education

With the rise of smartphones, digital health technology has become a powerful tool in patient education and monitoring. Mobile applications are now being used to collect patient data, facilitate communication between patients and providers, and most importantly, improve patient outcomes. This has been proven to be successful in the management of diseases such as diabetes and chronic heart disease. Mobile apps for Gastroenterological and orthopaedic surgery reduce follow-up visits and monitor postoperative wounds. Prostate-, and lung cancer, and C-section postoperative outcomes can also be collected via mobile apps.

The Efficacy of Digital Health Platforms: A Case Study

A recent study focused on the effectiveness of a mobile digital health platform, ManageMySurgery (MMS). MMS is a mobile app that supports patients during interventional procedures. This app contains links about surgery, care team communication, and duties to prepare patients for their treatments. It also serves as a reminder for checking into appointments, confirming preoperative instructions, and completing pre- and post-op surveys. The results were impressive, with significant reductions in emergency room visits, hospital readmissions, and complications among patients using the app.

Understanding the Mechanism of Benefit

This digital health application stands as one of the first for cardiac surgery shown to improve patient outcomes through objective measurements. While it’s not possible to prove direct causality, the study’s results suggest that digital health tools can significantly improve patient outcomes including reduced rehospitalisation and emergency room visits. These apps serve as partners in patients’ journeys, reminding them of actions they need to take before and after surgery. This ensures improved outcomes and a better quality of life.

Limitations and Future Directions

Despite the promising results, the study was not without limitations, including the potential for selection bias and the fact that it focused solely on TAVR patients. Future studies could expand the focus to include a wider variety of cardiothoracic procedures and explore the potential benefits of integrating the app with electronic medical records.

The Future of Digital Health in Healthcare

This study represents a significant step forward in understanding the potential of digital health platforms in improving patient outcomes. By engaging patients throughout every step of their surgical procedure, digital health tools can help improve individual patient wellbeing. Resulting in reduced the workload on healthcare providers, and assisting with alleviating the overall burden on healthcare resources.

Reference url

Recent Posts

capivasertib cost-effectiveness
      

Capivasertib Cost-Effectiveness in Advanced Breast Cancer

💡What’s the strategy to bring capivasertib’s price within reach of breast cancer patients?

A recent study evaluates capivasertib, an AKT inhibitor, as a second-line treatment for advanced breast cancer, revealing that its costs significantly outweigh the added health benefits. The analysis indicates that to be cost-effective, a substantial reduction in its price is necessary.

Delve into the economic implications of this treatment and the pressing need for pricing reforms in healthcare.

#SyenzaNews #HealthEconomics #costeffectiveness #oncology

reserve antibiotics benefits
           

Reserve Antibiotics Benefits: G-BA Designates Meropenem/Vaborbactam as Critical Reserve Treatment

🔍 What makes reserve antibiotics crucial in the fight against antimicrobial resistance?

The recent assessment of Meropenem/Vaborbactam by the G-BA highlights its vital role as a reserve antibiotic for severe gram-negative infections, ensuring effective treatment options when others fail. With tight regulations and stewardship in place, its designation underscores the importance of preserving these powerful tools in modern medicine.

Dive into the article to explore the implications for healthcare, economics, and patient safety.

#SyenzaNews #HealthcareInnovation #HealthEconomics

robotic surgery approval
               

NICE Grants Conditional Robotic Surgery Approval to Enhance Patient Care and Address Health Inequities

🤖 Are you ready for the future of surgery?

The recent approval of 11 robotic surgery systems by NICE could improve patient care in the NHS, leading to faster recoveries and minimal invasiveness. With a focus on real-world evidence, this transformative step aims to improve health outcomes while addressing access and equity concerns.

Explore how this innovative approach will shape the landscape of surgical procedures in the coming years!

#SyenzaNews #HealthcareInnovation #MedicalDevices #MarketAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.